Bailard’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$724K Buy
66,300
+38,800
+141% +$426K 0.01% 434
2026
Q2
$252K Hold
27,500
– – 0.01% 686
2026
Q1
$298K Buy
+27,500
New +$235K 0.01% 599
2025
Q3
– Sell
-32,600
Closed -$193K – 860
2025
Q2
$193K Buy
32,600
+14,881
+84% +$89.6K ﹤0.01% 725
2025
Q1
$146K Sell
17,719
-9,551
-35% -$80.1K ﹤0.01% 706
2024
Q4
$225K Buy
+27,270
New +$219K 0.01% 662
2024
Q2
– Sell
-17,600
Closed -$210K – 797
2024
Q1
$210K Sell
17,600
-13,398
-43% -$149K 0.01% 680
2023
Q4
$335K Sell
30,998
-8,200
-21% -$100K 0.01% 535
2023
Q3
$542K Sell
39,198
-11,500
-23% -$168K 0.02% 399
2023
Q2
$607K Buy
+50,698
New +$572K 0.02% 351
2020
Q4
– Sell
-21,600
Closed -$62K – 667
2020
Q3
$62K Buy
+21,600
New +$79.4K ﹤0.01% 540

Other funds holding PTEN

Bailard's PTEN Position: Q3 2026 in Review

Bailard increased its Patterson-UTI (PTEN) stake by 141% in Q3 2026, buying an estimated $426K and bringing the position to 66,300 shares worth $724K. The position accounts for 0.01% of the portfolio, ranked #434.

Bailard first reported a position in PTEN in Q3 2020 and has held it in 11 quarters since. 53 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.

  • Bailard held 66,300 shares of Patterson-UTI worth $724K as of Q3 2026.
  • Bailard bought 38,800 Patterson-UTI shares in Q3 2026, an estimated $426K.
  • Patterson-UTI made up 0.01% of Bailard's portfolio in Q3 2026, its #434 holding.
  • Bailard first reported a position in Patterson-UTI in Q3 2020 and has held it in 11 quarters since.
  • 53 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.